Gentler bone marrow transplant shows promise for kids with blood disorders
NCT ID NCT01050855
First seen May 11, 2026 · Last updated May 11, 2026
Summary
This study tests a milder chemotherapy regimen before a bone marrow or cord blood transplant in children and young adults (ages 6 months to 25 years) with non-cancerous blood disorders like sickle cell disease, thalassemia, and immune deficiencies. The goal is to see if this gentler approach helps donor cells successfully engraft while causing fewer side effects than standard transplants. The study is active but no longer recruiting new participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOGLOBINOPATHIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.